Harvard Comprehensive Updates in Nephrology 2026
$1,475.00 Original price was: $1,475.00.$149.00Current price is: $149.00.
4.9
(157 reviews)
🩺 Harvard comprehensive nephrology update — CKD progression & SGLT2 inhibitors, acute kidney injury, glomerular disease, electrolyte & acid-base disorders, dialysis, transplantation, cardiorenal syndrome, onconephrology, and genetic kidney disease. 104 Videos + 54 PDFs + Subtitles · 179.82 GB.
72 viewing now
Secure payment via
| 🔒 Secure Checkout |
↩️ 30-Day Refund |
♾️ Lifetime Access |
✅ Instant Download |
Harvard Comprehensive
Updates in Nephrology 2026
Harvard-Affiliated Faculty · Expert-Led Clinical Update
104 Videos + 54 PDFs + Subtitles · 179.82 GB — Instant Digital Access
⚡ INSTANT DIGITAL ACCESS
Includes: 92 (+12) Videos + 92 (+48) Subtitle Files (.vtt) + 54 PDFs | Total Size: 179.82 GB | Google Drive delivery
📚 About This Course
Harvard Comprehensive Updates in Nephrology 2026 delivers a practical, evidence-based review of kidney disease across the full clinical spectrum — from early chronic kidney disease through dialysis and transplantation.
Nephrology has changed faster in the last five years than in the previous twenty. SGLT2 inhibitors, non-steroidal MRAs, GLP-1 receptor agonists and updated KDIGO guidance have redefined how CKD is managed. This course brings those changes into clear, applicable clinical practice.
Designed for clinicians who manage kidney disease daily — nephrologists, internists, hospitalists, and primary care physicians caring for patients with CKD, AKI and electrolyte disorders.
🎯 Four Core Learning Areas
💡 Key Topics Covered
👨⚕️ Who Should Take This Course
✅ What You’ll Be Able to Do
Apply current guideline-based therapy to slow CKD progression
Select and dose SGLT2 inhibitors, MRAs and GLP-1 agonists appropriately
Evaluate and manage acute kidney injury across clinical settings
Diagnose and manage common glomerular diseases with current therapies
Correct complex electrolyte and acid-base disturbances confidently
Counsel patients on dialysis modality choice and transplant candidacy
⭐ What Clinicians Say
“The SGLT2 and finerenone sections alone changed how I manage my CKD patients. Very practical and current.”
Dr. Rachel T. — Nephrologist
“Excellent electrolyte and acid-base content. Clear enough to apply immediately on the wards.”
Dr. James O. — Hospitalist
“As a primary care physician I now feel far more confident managing early CKD before referral.”
Dr. Priya K. — Family Medicine
$149
Complete Harvard nephrology update — 104 videos + 54 PDFs + subtitles · 179.82 GB. Instant access, lifetime learning.
Our support team is available around the clock — email us at support@medicalosa.com and we’ll get back to you quickly.
